Multiplex gene expression analysis for high-throughput drug discovery: Screening and analysis of compounds affecting genes overexpressed in cancer cells

Molecular Cancer Therapeutics

Volumn 1, Issue 14, 2002, Pages 1293-1304

  Johnson, Paul H ^a   Walker, Roger P ^b,c   Jones, Steven W ^a   Stephens, Kathy ^b,d   Meurer, Janet ^a   Zajchowski, Deborah A ^a   Luke, May M ^a,e   Eeckman, Frank ^b,f   Tan, Yuping ^b,d   Wong, Linda ^b,c   Parry, Gordon ^a   Morgan Jr , Thomas K ^a   McCarrick, Meg A ^a,g   Monforte, Joseph ^b,h  

^a BAYER AG   (Germany)

^b GeneTrace Systems Inc   (United States)

^c ILLUMINA INC   (United States)

^d ACLARA BioSciences Inc   (United States)

^e CELERA   (United States)

^f Centient Consulting Inc   (United States)

^g Signal Pharmaceuticals   (United States)

^h Althea Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CCAAT ENHANCER BINDING PROTEIN; COLORING AGENT; CYCLOPHILIN; DDIT3 PROTEIN, HUMAN; DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAT SHOCK PROTEIN 70; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN; SIGNAL PEPTIDE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CHEMICAL MODEL; DRUG DESIGN; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IC 50; KINETICS; MALE; METABOLISM; NEOPLASM; PROSTATE TUMOR; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TIME; UPREGULATION;

ACTINS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; COLORING AGENTS; CYCLOPHILINS; DNA; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MALE; MODELS, CHEMICAL; NA(+)-K(+)-EXCHANGING ATPASE; NEOPLASMS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROSTATIC NEOPLASMS; PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0038380368     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Young, R. A. Biomedical discovery with DNA arrays. Cell, 102: 9-15, 2000.
2. Debouck, C., and Goodfellow, P. N. DNA microarrays in drug discovery and development. Nat. Genet. Suppl., 21: 48-50, 1999. (Pubitemid 29031492)
3. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y., Su, Y. A., and Trent, J. M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet., 14: 457-460, 1996. (Pubitemid 26414590)
4. Zajchowski, D. A., Bartholdi, M. F., Gong, Y., Webster, L., Liu, H-L., Munishkin, A., Beauheim, C., Harvey, S., Ethier, S. P., and Johnson, P. H. Gene expression profiles predict the aggressive behavior of breast cancer cells in highly aggressive carcinomas. Cancer Res., 61: 5168-5178, 2001. (Pubitemid 32681550)
5. Clarke, P. A., te Poele, R., Wooster, R., and Workman, P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem. Pharmacol., 62: 1311-1336, 2001. (Pubitemid 33044679)
6. Rose, A. M., and Valdes, R., Jr. Understanding the sodium pump and its relevance to disease. Clin. Chem., 40: 1674-1685, 1994. (Pubitemid 24273087)
7. 2+ increases and apoptosis in androgenindependent, metastatic human prostate adenocarcinoma cells. Cancer Res., 60: 3807-3812, 2000.
8. Tan, A. S., and Berridge, M. V. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J. Immunol. Methods, 238: 59-68, 2000. (Pubitemid 30175986)
9. Devlin, J. J., Liang, A., Trinh, L., Polokoff, M. A., Senator, D., Zheng, W., Kondracki, J., Kretschmer, P. J., Morser, J., Lipson, S. E., Spann, R., Loughlin, J. A., Dunn, K. V., and Morrissey, M. M. High capacity screening of pooled compounds: identification of the active compound without re-assay of pool members. Drug Dev. Res., 37: 80-85, 1996. (Pubitemid 26146778)
10. Erusalimsky, J. D., John, J., Hong, Y., and Moore, M. A Glass fiber/DEAE double filter binding assay that measures apoptotic internucleosomal DNA fragmentation. Anal. Biochem., 242: 187-196, 1996. (Pubitemid 26386813)
11. Sreenath, T., Orosz, A., Fujita, K., and Bieberich, C. J. Androgenindependent expression of hoxb-13 in the mouse prostate. Prostate, 41: 203-207, 1999. (Pubitemid 29508615)
12. Oettgen, P., Finger, E., Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, A., Brown, L., Quinn, G., Kas, K., Endress, G., Kunsch, C., and Libermann, T. A. PDEF, a novel prostate epitheliumspecific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem., 275: 1216-1225, 2000. (Pubitemid 30051174)
13. Nozawa, M., Yomogida, K., Kanno, N., Nonomura, N., Miki, T., Okuyama, A., Nishimune, Y., and Nozaki, M. Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res., 60: 1348-1352, 2000. (Pubitemid 30152005)
14. Ye, H., Kelly, T. F., Samadani, U., Lim, L., Rubio, S., Overdier, D. G., Roebuck, K. A., and Costa, R. H. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol., 17: 1626-1641, 1997. (Pubitemid 27097392)
15. Ambrosini, G., Adida, C., and Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 8: 917-921, 1997. (Pubitemid 27353455)
16. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (Lond.), 396: 580-584, 1998. (Pubitemid 28563719)
17. Xu, X. Z., Choudhury, A., Li, X., and Montell, C. Coordination of an array of signaling proteins through homo- and heteromeric interactions between PDZ domains and target proteins. J. Cell Biol., 142: 545-555, 1998. (Pubitemid 28361559)
18. Freeman, W. M., Walker, S. J., and Vrana, K. E. Quantitative RT-PCR: pitfalls and potential. BioTechniques, 26: 112-125, 1999. (Pubitemid 29031577)
19. Mehanna, A. S. Chapter 19: Cardiac Agents. In: W. O. Foye, T. L. Lemke, and D. A. Williams (eds.), Principles of Medicinal Chemistry, 4th ed., pp. 366-371. Media, Pennsylvania: Lippincott, Williams, & Wilkins, 1995.
20. Masuda, Y., Kawazoe, N., Nakajo, S., Yoshida, T., Kuroiwa, Y., and Nakaya, K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res., 19: 549-556, 1999.
21. Harrold, S., Genovese, C., Kobrin, B., Morrison, S. L., and Milcarek, C. A comparison of apparent mRNA half-life using kinetic labeling techniques versus decay following administration of transcriptional inhibitors. Anal. Biochem., 198: 19-29, 1991.
22. Goodisman, J., Rehfuss, R., Ward, B., and Dabrowiak, J. C. Sitespecific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry, 31: 1046-1058, 1992.
23. +-transporting ATPase in prescreens for anti-cancer agents. Anticancer Drug Design, 10: 177-187, 1995.
24. Haux, J. Digitoxin is a potential anticancer agent for several types of cancer. Med. Hypotheses, 53: 543-548, 1999. (Pubitemid 30064132)
25. Stenkvist, B. Is digitalis a therapy for breast carcinoma? Oncol. Rep., 6: 493-496, 1999.
26. Blanco, G., and Mercer, R. W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol., 275: 633-650, 1998.
27. Furuya, Y., Lundmo, P., Short, A. D., Gill, D. L., and Isaacs, J. T. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res., 54: 6167-6175, 1994.
28. + efflux in the activation of apoptosis. J. Biol. Chem., 272:32436-32442, 1997.
29. McConkey, D. J., and Orrenius, S. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun., 239: 357-366, 1997. (Pubitemid 27488969)
30. +-ATPase in androgendependent and androgen-independent prostate cancer. Br. J. Cancer, 81: 28-36, 1999.
31. 2+ increases transcriptional activity and mRNA stability. J. Biol. Chem., 267: 20465-20470, 1992.
32. Matsumoto, M., Minami, M., Takeda, K., Sakao, Y., and Akira, S. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett., 395: 143-147, 1996. (Pubitemid 26356172)
33. Eymin, B., Dubrez, L., Allouche, M., and Solary, E. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. Cancer Res., 57: 686-695, 1997. (Pubitemid 27085652)
34. Seth, A., Giunta, S., Franceschil, C., Kola, I., and Venanzoni, M. C. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products. Cell Death Differ., 6: 902-907, 1999. (Pubitemid 29488088)
35. Sheikh, M. S., Hollander, M. C., and Fornance, A. J., Jr. Role of Gadd45 in apoptosis. Biochem. Pharmacol., 59: 43-45, 2000.
36. Harkin, D. P., Bean, J. M., Miklos, D., Song, Y. H., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., and Haber, D. A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell, 97: 575-586, 1999. (Pubitemid 29256961)
37. Yamada, K., Hino, K., Tomoyasu, S., Honma, Y., and Tsuruoka, N. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture. Leuk. Res, 22: 589-595, 1998. (Pubitemid 28327461)
38. Yi, Y. W., Kim, D., Jung, N., Hong, S. S., Lee, H. S., and Bae, I. Gadd45 family proteins are coactivators of nuclear hormone receptors. Biochem. Biophys. Res. Commun., 272: 193-198, 2000. (Pubitemid 30444921)
39. Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., and Altieri, D. C. Pleiotropic celldivision defects and apoptosis induced by interference with survivin function. Nat. Cell. Biol., 1: 461-466, 1999. (Pubitemid 129503664)
40. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., and Murphy, M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem., 277: 3247-3257, 2002. (Pubitemid 34953189)
41. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev., 15: 61-79, 1994.
42. Pasquali, D., Rossi, V., Prezioso, D., Gentile, V., Colantuoni, V., Lotti, T., Bellastella, A., and Sinisi, A. A. Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells. J. Clin. Endocrinol. Metab., 84: 1463-1469, 1999. (Pubitemid 30644416)
43. Nagy, L., Thomazy, V. A., Chandraratna, R. A., Heyman, R. A., and Davies, P. J. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leuk. Res., 6: 499-505, 1996. (Pubitemid 26254539)
44. Stoler, D. L., Chen, N., Basik, M., Kahlenberg, M. S., Rodriguez-Bigas, M. A., Petrelli, N. J., and Anderson, G. R. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. USA, 96: 15121-15126, 1999. (Pubitemid 30019775)
45. Cahill, D. P., Kinzler, K. W., Vogelstein, B., and Lengauer, C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol, 9: M57-M60, 1999.
46. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Wash. DC), 276: 1268-1272, 1997. (Pubitemid 27227367)